[HTML][HTML] The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy

C Grinán-Ferré, A Bellver-Sanchis, V Izquierdo… - Ageing research …, 2021 - Elsevier
While the elderly segment of the population continues growing in importance,
neurodegenerative diseases increase exponentially. Lifestyle factors such as nutrition …

The biphasic function of microglia in ischemic stroke

Y Ma, J Wang, Y Wang, GY Yang - Progress in neurobiology, 2017 - Elsevier
Microglia are brain resident macrophages originated from primitive progenitor cells in the
yolk sac. Microglia can be activated within hours and recruited to the lesion site …

siRNA versus miRNA as therapeutics for gene silencing

JKW Lam, MYT Chow, Y Zhang, SWS Leung - Molecular therapy Nucleic …, 2015 - cell.com
Discovered a little over two decades ago, small interfering RNAs (siRNAs) and microRNAs
(miRNAs) are noncoding RNAs with important roles in gene regulation. They have recently …

Aging and Alzheimer's disease: comparison and associations from molecular to system level

X **a, Q Jiang, J McDermott, JDJ Han - Aging cell, 2018 - Wiley Online Library
Alzheimer's disease is the most prevalent cause of dementia, which is defined by the
combined presence of amyloid and tau, but researchers are gradually moving away from the …

The epigenetics of aging and neurodegeneration

R Lardenoije, A Iatrou, G Kenis, K Kompotis… - Progress in …, 2015 - Elsevier
Epigenetics is a quickly growing field encompassing mechanisms regulating gene
expression that do not involve changes in the genotype. Epigenetics is of increasing …

Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers

M Li, E Zeringer, T Barta… - … of the Royal …, 2014 - royalsocietypublishing.org
Exosomes are tiny vesicles (30–150 nm) constantly secreted by all healthy and abnormal
cells, and found in abundance in all body fluids. These vesicles, loaded with unique RNA …

Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of …

K Burgos, I Malenica, R Metpally, A Courtright… - PloS one, 2014 - journals.plos.org
The discovery and reliable detection of markers for neurodegenerative diseases have been
complicated by the inaccessibility of the diseased tissue-such as the inability to biopsy or …

Therapeutics in the pipeline targeting α-synuclein for Parkinson's disease

HG Jasutkar, SE Oh, MM Mouradian, E Barker - Pharmacological reviews, 2022 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder and the
fastest growing neurologic disease in the world, yet no disease-modifying therapy is …

MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS

ED Ponomarev, T Veremeyko, HL Weiner - Glia, 2013 - Wiley Online Library
MicroRNAs (miRNAs) are a class of small (∼ 22 nucleotides) noncoding RNAs involved in
the regulation of gene expression at the post‐translational level. It is estimated that 30–90 …

Parkinson's disease as a result of aging

M Rodriguez, C Rodriguez‐Sabate, I Morales… - Aging cell, 2015 - Wiley Online Library
It is generally considered that Parkinson's disease is induced by specific agents that
degenerate a clearly defined population of dopaminergic neurons. Data commented in this …